Coriell Life Sciences' GeneDose™ is a medication risk management tool empowering physicians through simplified genomics. Learn More ›
Coriell Life Sciences wins the 2015 IBM Beacon Award, a prestigious distinction honoring an elite group of business partners. Learn More ›
Coriell Life Sciences is a dynamic for-profit genomic storage and interpretation venture. Learn More ›
Coriell Life Sciences wins IBM's coveted "Entrepreneur of the Year" award at the global finals. Learn More ›
Coriell Life Sciences offers a novel approach to genomic testing. Test once, store securely, and access expert interpretations when needed.
Taking advantage of the falling cost of genome sequencing, this new approach offers healthcare providers access to the world's leading experts in genomic interpretation, while delivering the concise clinical data they need for patient care.
Our core product – GeneDose – seamlessly integrates genomic medicine into clinical care while managing the breadth of information that is obtained through genomic sequencing.
The Coriell Life Sciences ecosystem allows healthcare providers, patients and payors to take advantage of the available sequencing technology while carving out and interpreting only that data needed for immediate use and securely storing the data for future interpretation.
Find out more about the cutting-edge research that created CLS happening at the Coriell Institute for Medical Research.
In the News
Coriell Life Sciences is helping to usher in an era of genomic medicine.
May 12, 2015
February 12, 2015
February 11, 2015
February black porn 9, 2015
February 9, 2015